Press-release for stocks in the professional, scientific, and technical services sector related to biomidwest

Prices are updated after-hours

sector : Professional, scientific, and technical services tags : Biomidwest

save search

Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of FlynpoviPatent developed in collaboration with Sanofi
Published: 2023-09-05 (Crawled : 20:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -98.19% | O: 1.38% H: 4.76% C: -0.68%
SNY | News | $46.125 0.71% 0.7% 3.7M

Health Technology

| -14.53% | O: -0.93% H: 0.0% C: 0.0%
patent collaboration sanofi

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med
Published: 2023-04-10 (Crawled : 12:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| 118.71% | O: 5.81% H: 1.22% C: -0.91%
ceo cell meeting

Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Endocrine Society Meeting
Published: 2023-04-06 (Crawled : 14:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -94.66% | O: 2.29% H: 16.42% C: 6.0%
presentation endocrine meeting

Panbela Announces New Research Agreement with Johns Hopkins University School of Medicine
Published: 2023-04-03 (Crawled : 14:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -96.04% | O: 1.76% H: 2.22% C: -7.11%
research agreement

Panbela Announces Issuance of New Patent in Japan; Patent is for Claims of a Novel Process for the Production of SBP-101
Published: 2023-03-22 (Crawled : 14:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -96.7% | O: -1.89% H: 9.58% C: 1.92%
sbp-101 patent

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023
Published: 2023-03-20 (Crawled : 22:00) - biospace.com/
ABOS | $3.475 -0.71% -0.72% 150K

Professional, Scientific, and T...

| -9.56% | O: -0.26% H: 3.35% C: -2.85%
report pharmaceuticals financial results

Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum
Published: 2023-03-08 (Crawled : 01:00) - biospace.com/
ABOS | $3.475 -0.71% -0.72% 150K

Professional, Scientific, and T...

| -35.9% | O: -0.18% H: 4.04% C: 1.28%
pharmaceuticals

Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Published: 2023-02-01 (Crawled : 15:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| -2.87% | O: -0.57% H: 5.19% C: -9.8%
BAX | News | $39.52 -0.13% 0.0% 2.8M

Health Technology

| -13.39% | O: 0.44% H: 1.04% C: 0.85%
care research liver agreement

Panbela Announces Adoption of Commission Implementing Decision from the EMA for the Orphan Designation of Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published: 2023-01-19 (Crawled : 17:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -99.48% | O: 9.82% H: 7.86% C: -11.11%
sbp-101 designation ema gemcitabine pancreatic

Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
ABOS | $3.475 -0.71% -0.72% 150K

Professional, Scientific, and T...

| -33.46% | O: -1.33% H: 7.32% C: 5.2%
pharmaceuticals

Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Published: 2022-11-28 (Crawled : 16:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...

| -99.67% | O: 5.66% H: 0.07% C: -10.71%
sbp-101 europe aspire trial gemcitabine pancreatic

Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for Alzheimer's Disease
Published: 2022-10-24 (Crawled : 14:00) - biospace.com/
ABOS | $3.475 -0.71% -0.72% 150K

Professional, Scientific, and T...

| -54.19% | O: 1.44% H: 3.69% C: -1.94%
acu193 fda designation disease alzheimer's granted anti-amyloid beta fast track designation

Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa
Published: 2022-10-05 (Crawled : 23:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| -22.25% | O: -1.15% H: 1.86% C: -5.57%
ceo meeting

Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
Published: 2022-09-26 (Crawled : 22:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| -3.97% | O: 4.53% H: 4.61% C: 0.78%
ceo

Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology
Published: 2022-08-25 (Crawled : 12:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| 22.83% | O: 19.2% H: 0.0% C: -14.29%
patent technology

Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase
Published: 2022-08-23 (Crawled : 12:20) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| 23.27% | O: 0.36% H: 1.09% C: -0.36%
growth

Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
Published: 2022-08-15 (Crawled : 01:00) - biospace.com/
MIRO | $3.39 3.25% 630K

Professional, Scientific, and T...

| 22.12% | O: 1.22% H: 0.0% C: -1.78%
update results

Panbela Provides Business Update and Reports Q2 2022 Financial Results
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
PBLA | $0.525 -6.31% 38K

Professional, Scientific, and T...